EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms
Join us for this unique and rare opportunity and exchange ideas with MDS, MPN, and AML experts in one meeting. Internationally renowned experts will provide presentations and share the recent developments and answers to your clinical questions.
Dates: November 2-4, 2023
Location: Budapest, Hungary
Chairs: U Platzbecker, K Döhner, C Harrison
Co-chairs: S Kordasti, G Ossenkoppele, JJ Kiladjian
- EHA Specialized Working Group on Myelodysplastic Syndromes (MDS)
- EHA Specialized Working Group on Myeloproliferative Neoplasms (MPN)
- EHA Specialized Working Group on Acute Myeloid Leukemia
The meeting is intended for hematologists, internists, (biomedical) scientists, (specialist) nurses, lab specialists, patient advocates, and trainees.
This is an important meeting for clinicians and scientists in the field of myeloid malignancies as experts in MDS, MPN and AML are getting together to provide an update on the current understanding of the pathophysiology, novel treatments and future of therapy. It would be a great and rare opportunity to meet these experts in one place, exchange ideas and ask questions. The meeting will cover the following topics:
- Commonalities and Differences of MDS, MPN and AML
- Genomics in MPN, MDS, AML
- HSC Niche
- Immunome in MPN, MDS and AML
- Development of biomarkers of disease progression
- Translating Omics to Clinical Tests
- Novel therapies
- HSC transplant and cell therapy
There are various opportunities to support this meeting. For more information please send an email to firstname.lastname@example.org.
Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.